Revenue: The sum of all revenue fields included for a company's operating activities.
Novo Nordisk A/S (NVO) had Revenue of $46.79B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$46.79B |
$15.51B |
|
$8.90B |
|
$37.89B |
|
$27.46B |
|
$19.33B |
|
$436.33M |
|
$19.76B |
|
$19.76B |
|
$15.51B |
|
$15.51B |
|
$15.51B |
|
$15.51B |
|
$19.33B |
|
$22.66B |
|
4.44B |
|
4.45B |
|
$3.49 |
|
$3.49 |
|
| Balance Sheet Financials | |
$26.11B |
|
$31.55B |
|
$56.09B |
|
$82.20B |
|
$32.65B |
|
$18.01B |
|
$20.17B |
|
$52.82B |
|
$29.38B |
|
$9.69B |
|
$29.38B |
|
4.46B |
|
| Cash Flow Statement Financials | |
$18.03B |
|
$-11.98B |
|
$-4.30B |
|
$2.37B |
|
$4.01B |
|
$1.64B |
|
$217.26M |
|
$-7.84B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.80 |
|
-- |
|
-- |
|
0.38 |
|
0.67 |
|
80.98% |
|
41.30% |
|
41.30% |
|
48.42% |
|
42.24% |
|
33.14% |
|
$8.93B |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
1.18 |
|
3.47 |
|
105.33 |
|
52.79% |
|
160.07% |
|
18.87% |
|
32.73% |
|
$6.58 |
|
$2.01 |
|
$4.05 |
|